HIV and Anemia: One Patient's... Video Transcript

Media Gallery

HIV and Anemia: An Overlooked Danger
Communicating HIV Treatment Side Effects with Your Doctor
Treatment of HIV: A Guide For Patients and Doctors
Adherence in HIV Disease: How One Person Keeps on Track
Once-Daily Medicines for HIV Disease
HIV Medicines and Cholesterol: Is There a Link?
Update on Lipodystrophy in HIV
HIV Therapy: What is HAART?
One Man Faces the Challenges of Cholesterol and HIV
Lipodystrophy in HIV Disease
Liver Problems with HIV Medications
The Grim Reaper: Club Drugs And HIV
Fast and Easy HIV Testing
Making The Decision To Start HIV Therapy
Sticking to It: An HIV Patient Discusses Adherence
Dealing with Wasting in HIV Disease
Why Adherence Matters for Antiretrovirals
Coping With HIV Drugs: A Personal Story
Central Nervous System Side Effects from HIV Treatment
Advertisement
Marketplace
HIV and Anemia: One Patient's Story
Play Videoplay videoTime: 07:19 minutes
Licensed from
Page: 1 2 Next >

Participants

, Brian A. Boyle MD, Martin Gonzalez-R

Summary

It's been estimated that up to 95% of people infected with HIV will experience anemia at some point. Unfortunately, it is often overlooked, and untreated anemia can lead to dangerous complications. Join Dr. Lisa Capaldini and Dr. Brian Boyle as they discuss symptoms, diagnosis, and treatment options, and share important advice for those living with HIV.

Webcast Transcript

VAREN BLACK: I'm Varen Black, and welcome to our webcast. It's been estimated that up to 95% of people infected with HIV will experience anemia over the course of the disease, but anemia is often overlooked and cause serious consequences in a patient's quality of life.

Here with me to talk more about anemia and HIV is Martin Gonzalez-Rojas, who is living with AIDS. Martin, thank you for being with us today.

MARTIN GONZALEZ-ROJAS: Thank you for inviting me.

VAREN BLACK: Let's start off with a little background information. What symptoms were you experiencing that made you think something was wrong?

MARTIN GONZALEZ-ROJAS: I believe that I experienced anemia, or at least I knew that there was something wrong with me. A year, almost, I was released from the hospital and was diagnosed with AIDS. I was feeling tired on a daily basis and sleepy almost the entire day. Weak -- that's probably the one word that I can use to summarize. I was weak altogether, whether it was physically or mentally. At that time I was taking AZT and 3TC, so on one particular doctor visit, I asked my doctor about the side effects associated with the regimen, so he suggested for me to have some sort of testing done, and after almost a week and a half, he came back to me and he said that I was having low red cell counts and that possibly I could be developing anemia.

VAREN BLACK: How did the anemia affect your lifestyle? Could you go to work?

MARTIN GONZALEZ-ROJAS: I was able to go to work, but I think it affected me in ways where I was not able to concentrate appropriately. At that time I was working for a law firm. I was working on pleadings and legal documents, and I was just tired the entire day and I wanted to take a nap just about every hour, so my concentration was not totally there, and I think in that regard it affected me.

VAREN BLACK: What was the process that the doctor used to find out what was wrong with you? What kind of tests were done?

MARTIN GONZALEZ-ROJAS: When I went back to see my doctor and I discussed with him the side effects that I was experiencing, he had a few ideas. AZT was one of the medications that I was taking, and one of the side effects was anemia and fatigue. So he suggested to draw some blood, to run some tests and to discuss my case with other colleagues of his, so he suggested for me to stop taking AZT and to consider other options.

VAREN BLACK: What treatment options were you offered, and which ones did you choose, and why?

MARTIN GONZALEZ-ROJAS: At that time, I was given two options. One of them included Crixivan, a protease inhibitor, along with other medications that I don't remember. And then the second option was Norvir, Fortovase, Videx and one of the medications that I was taking at that time. In doing some background information about the two regimens that I was given, I chose not to go with Crixivan because of the requirements, the requirements such as taking a lot of water or fluids, and also taking the medication with low-fat meals, and the reality is that in my culture, we're not accustomed to eating foods that are low in fat, and on a personal note, I just don't take a lot of water on a daily basis. So I decided to go with the second option, which was Fortovase and Norvir and Videx, simply because I felt that the second option was not as complex.

VAREN BLACK: Was dosage ever a factor in your decision?

MARTIN GONZALEZ-ROJAS: To some degree dosage was a factor. I believe that the more simplistic you get into it, the better. When you have to be concerned about every eight hours or multiple dosage, meaning that you have to take one in the morning, one in the afternoon, and then one at night, I think it becomes more complex.

Page: 1 2 Next >
 
Related Learning
Centers
·As a Test
·As a Complication

Advertisement
Back to Top